Sendek Joel
Insider CIK 1720875 · SPRO Chief Financial Officer · CATX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics, | A Award deriv | 2025-09-04 | 2025-09-05 | 600,000 | — | $0 | 600,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2018-07-05 | 2018-07-06 | 2,000 | — | $0 | 165,833 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-05 | 2018-07-06 | 2,000 | $17.50 | $35.0K | 15,181 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2018-07-05 | 2018-07-06 | 2,000 | $5.90 | $11.8K | 17,181 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2017-12-13 | 2017-12-15 | 27,795 | — | $0 | 27,795 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 61,880 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | P Buy | 2017-11-06 | 2017-11-07 | 5,000 | $14.00 | $70.0K | 15,181 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 10,181 | — | $0 | 10,181 | SEC↗ |